Friedenthal Financial Acquires Shares of 1,189 SPDR S&P Biotech ETF (NYSEARCA:XBI)

Friedenthal Financial bought a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the third quarter, according to its most recent Form 13F filing with the SEC. The firm bought 1,189 shares of the exchange traded fund’s stock, valued at approximately $117,000.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Affinity Asset Advisors LLC raised its position in shares of SPDR S&P Biotech ETF by 105.4% during the 2nd quarter. Affinity Asset Advisors LLC now owns 37,550 shares of the exchange traded fund’s stock valued at $3,481,000 after buying an additional 737,550 shares during the period. Healthcare of Ontario Pension Plan Trust Fund grew its holdings in shares of SPDR S&P Biotech ETF by 30.3% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock worth $297,575,000 after purchasing an additional 730,000 shares during the period. Mirae Asset Securities USA Inc. acquired a new stake in shares of SPDR S&P Biotech ETF during the 2nd quarter worth about $55,626,000. Jane Street Group LLC raised its holdings in SPDR S&P Biotech ETF by 68.7% in the 1st quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock valued at $91,197,000 after buying an additional 391,333 shares during the period. Finally, Baymount Management LP purchased a new stake in SPDR S&P Biotech ETF in the 1st quarter valued at about $34,160,000.

SPDR S&P Biotech ETF Price Performance

Shares of XBI stock opened at $99.83 on Friday. SPDR S&P Biotech ETF has a 1-year low of $63.80 and a 1-year high of $103.52. The firm has a market cap of $7.61 billion, a PE ratio of 11.47 and a beta of 1.11. The company has a 50-day moving average of $99.08 and a two-hundred day moving average of $94.35.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.